GSK (LON:GSK) Share Price Crosses Above 200-Day Moving Average - What's Next?

Key Points

• GSK plc's shares have exceeded their 200-day moving average, with a trading high of GBX 1,631.50 ($21.87) and a last traded price of GBX 1,623.54 ($21.76).
• Analysts currently provide a consensus rating of Hold for GSK, with target prices ranging from GBX 1,450 to GBX 2,100.
• Insider activity shows confidence, as Wendy Becker purchased 526 shares at an average price of GBX 1,503, part of a total acquisition of 561 shares valued at $841,184 over the last 90 days.

Shares of GSK plc (LON:GSK - Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,437.30 ($19.26) and traded as high as GBX 1,631.50 ($21.87). GSK shares last traded at GBX 1,623.54 ($21.76), with a volume of 6,621,039 shares trading hands.

Analyst Ratings Changes

Several brokerages have recently commented on GSK. JPMorgan Chase & Co. restated an "under review" rating on shares of GSK in a research report on Friday, October 3rd. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a GBX 1,450 price target on shares of GSK in a research note on Thursday, July 31st. Shore Capital reissued a "buy" rating and issued a GBX 2,100 price objective on shares of GSK in a research report on Wednesday, August 27th. Finally, Berenberg Bank reaffirmed a "hold" rating and issued a GBX 1,600 price target on shares of GSK in a research report on Friday, July 18th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of GBX 1,637.50.

GSK Stock Performance

The company has a market capitalization of £65.86 billion, a PE ratio of 1,978.84, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81. The stock's fifty day simple moving average is GBX 1,479.35 and its 200-day simple moving average is GBX 1,437.30.

GSK (LON:GSK - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported GBX 75.30 earnings per share for the quarter. GSK had a net margin of 8.02% and a return on equity of 18.08%. As a group, equities analysts predict that GSK plc will post 175.980975 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Wendy Becker purchased 526 shares of the stock in a transaction that occurred on Friday, September 19th. The stock was acquired at an average price of GBX 1,503 per share, with a total value of £7,905.78. Over the last 90 days, insiders bought 561 shares of company stock worth $841,184. Insiders own 0.20% of the company's stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.